UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-03, Vol.20 (2), p.254-262

2017

Link zum Volltext

Verfügbarkeit prüfen

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

Clinical cancer research, 2015-06, Vol.21 (11), p.2520-2529

2015

Link zum Volltext

Verfügbarkeit prüfen

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach

Molecular carcinogenesis, 2010-04, Vol.49 (4), p.353-362

2010

Link zum Volltext

Verfügbarkeit prüfen

RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib

Molecular cancer therapeutics, 2013-06, Vol.12 (6), p.865-877

2013

Link zum Volltext

Verfügbarkeit prüfen

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

International journal of cancer, 2013-05, Vol.132 (9), p.2209-2216

2013

Link zum Volltext

Verfügbarkeit prüfen

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer

British journal of cancer, 2016-07, Vol.115 (2), p.164-171

2016

Link zum Volltext

Verfügbarkeit prüfen

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

BMC cancer, 2008-10, Vol.8 (1), p.307-307, Article 307

2008

Link zum Volltext

Verfügbarkeit prüfen

Novel graded prognostic assessment for colorectal cancer patients with brain metastases

International journal of clinical oncology, 2018-12, Vol.23 (6), p.1112-1120

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic effects of abnormal DNA damage response protein expression in breast cancer

Breast cancer research and treatment, 2019-05, Vol.175 (1), p.117-127

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Clinical cancer research, 2006-04, Vol.12 (8), p.2538-2544

2006

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy‐resistant non‐small cell lung cancer

International journal of cancer, 2005-01, Vol.113 (1), p.109-115

2005

Link zum Volltext

Verfügbarkeit prüfen

Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-04, Vol.19 (2), p.597-606

2016

Link zum Volltext

Verfügbarkeit prüfen

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer

Cancer chemotherapy and pharmacology, 2011-10, Vol.68 (4), p.1045-1055

2011

Link zum Volltext

Verfügbarkeit prüfen

Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-04, Vol.19 (2), p.421-430

2016

Link zum Volltext

Verfügbarkeit prüfen

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Vol.20 (1), p.164-174

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer

Cancer research and treatment, 2017-10, Vol.49 (4), p.1077-1087

2017

Link zum Volltext

Verfügbarkeit prüfen

NFATC3-PLA2G15 Fusion Transcript Identified by RNA Sequencing Promotes Tumor Invasion and Proliferation in Colorectal Cancer Cell Lines

Cancer Research and Treatment, 2019, 51(1), , pp.391-401

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer

Patient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer

Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients

Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers

FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells

A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity

Antitumor activity of NVP‐AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins

Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach

RAD51C-deficient cancer cells are highly sensitive to the PARP inhibitor olaparib

Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

Novel graded prognostic assessment for colorectal cancer patients with brain metastases

Prognostic effects of abnormal DNA damage response protein expression in breast cancer

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy‐resistant non‐small cell lung cancer

Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer

Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer

Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer

NFATC3-PLA2G15 Fusion Transcript Identified by RNA Sequencing Promotes Tumor Invasion and Proliferation in Colorectal Cancer Cell Lines

Aktive Filter

Suchergebnisse filtern